国际妇产科学杂志 ›› 2023, Vol. 50 ›› Issue (5): 522-525.doi: 10.12280/gjfckx.20230567

• 产科生理及产科疾病:病例报告 • 上一篇    下一篇

完全性葡萄胎与胎儿共存一例并文献复习

李剑, 王冠   

  1. 300199 天津市中心妇产科医院产科/南开大学附属妇产医院;天津市人类发育与生殖调控重点实验室
  • 收稿日期:2023-07-22 出版日期:2023-10-15 发布日期:2023-10-16

Complete Hydatidiform Mole with Co-Existing Fetus: A Case Report and Literature Review

LI Jian, WANG Guan   

  1. Department of Obstetrics, Tianjin Central Hospital of Gynecology Obstetrics / Nankai University Maternity Hospital, Tianjin 300199, China; Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin 300199, China
  • Received:2023-07-22 Published:2023-10-15 Online:2023-10-16

摘要:

葡萄胎与胎儿共存(hydatidiform mole and co-existing fetus,HMCF)是产科的罕见疾病,包括完全性葡萄胎与胎儿共存(complete hydatidiform mole with co-existing fetus,CHMCF)和部分性葡萄胎与胎儿共存(partial hydatidiform mole with co-existing fetus,PHMCF)。报道1例CHMCF病例通过妊娠期连续监测甲状腺功能、人绒毛膜促性腺激素和胎儿状况妊娠至37周,剖宫产分娩一活婴。CHMCF是一种临床罕见的高风险疾病,妊娠期应联合超声、磁共振成像和染色体核型分析仔细鉴别诊断,并在有产前诊断和妇科肿瘤中心的机构严密监测妊娠、分娩及产后随访。

关键词: 妊娠,双胎, 葡萄胎, 妊娠滋养细胞疾病, 核型分析, 完全性葡萄胎与胎儿共存

Abstract:

Hydatidiform mole and co-existing fetus (HMCF) is a rare obstetric disease, including complete hydatidiform mole with co-existing fetus (CHMCF) and partial hydatidiform mole with a co-existing fetus (PHMCF). A case of CHMCF was reported by continuous monitoring of thyroid function, human chorionic gonadotropin and fetal status during pregnancy up to 37 weeks of gestation and delivery of a live infant by cesarean section. CHMCF is a clinically rare and high-risk disease. Therefore, pregnancy, parturition and postpartum follow-up should be carefully diagnosed and closely monitored through ultrasound, magnetic resonance imaging (MRI) and chromosomal karyotype analysis in institutions with prenatal diagnosis and gynecological oncology centers.

Key words: Pregnancy, twin, Hydatidiform mole, Gestational trophoblastic disease, Karyotyping, Complete hydatidiform mole with co-existing fetus